Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 421.23% | -16.13% | 36.37% | 1,537.32% | -55.36% |
| Total Depreciation and Amortization | 5.56% | 4.24% | 2.06% | -0.86% | -2.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -127.71% | -72.57% | -52.11% | -58.32% | 88.32% |
| Change in Net Operating Assets | 98.71% | -154.97% | -26.83% | -173.89% | -233.74% |
| Cash from Operations | 140.95% | -25.11% | -1.30% | 29.72% | -33.22% |
| Capital Expenditure | -9.42% | -25.25% | -73.93% | -39.55% | -8.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 85.97% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.29% | -150.30% | -20.89% | -122.22% | 164.39% |
| Cash from Investing | -96.18% | -94.48% | 0.04% | -69.20% | 23.05% |
| Total Debt Issued | 33.28% | -316.06% | 66.67% | 270.00% | -76.56% |
| Total Debt Repaid | 41.99% | 1,868.56% | -20.45% | 62.64% | 75.60% |
| Issuance of Common Stock | 29.53% | 13.74% | 457.78% | -11.11% | 186.54% |
| Repurchase of Common Stock | -224.60% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.40% | 0.40% | 0.00% | -0.20% | -0.40% |
| Other Financing Activities | -614.29% | 15.79% | -2,350.00% | -103.11% | 98.75% |
| Cash from Financing | 19.78% | -1.08% | 25.07% | -8.50% | 52.21% |
| Foreign Exchange rate Adjustments | -38.33% | 71.65% | 54.33% | 363.64% | 350.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.89% | -117.42% | 78.95% | -6.56% | 61.53% |